# SurgiMend in Two-stage Implant-based Breast Reconstruction in Patients With Pre-Mastectomy Radiotherapy

> **NCT01959867** · NA · WITHDRAWN · sponsor: **Integra LifeSciences Corporation**

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** SurgiMend® PRS
- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT01959867
- **Lead sponsor:** Integra LifeSciences Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-01
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01959867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01959867, "SurgiMend in Two-stage Implant-based Breast Reconstruction in Patients With Pre-Mastectomy Radiotherapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01959867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*